Chicago, IL10 Active Studies

Peripheral Artery Disease Clinical Trials in Chicago, IL

Find 10 actively recruiting peripheral artery disease clinical trials in Chicago, IL. Connect with local research sites and explore new treatment options.

10
Active Trials
3
Sponsors
21,624
Enrolling

Recruiting Peripheral Artery Disease Studies in Chicago

About Peripheral Artery Disease Clinical Trials in Chicago

Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.

There are currently 10 peripheral artery disease clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 21,624 participants. Research is being sponsored by Baylor Research Institute, Population Health Research Institute, Northwestern University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral Artery Disease Clinical Trials in Chicago — FAQ

Are there peripheral artery disease clinical trials in Chicago?

Yes, there are 10 peripheral artery disease clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What peripheral artery disease treatments are being tested?

The 10 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.

Data updated July 16, 2026 from ClinicalTrials.gov